CNTB is trading at $2.27 (6.9% up) in pre-market, extending a multi-day rebound from recent lows.

  • The move appears to be a momentum-driven continuation amid a broader risk-on tone in U.S. equity futures.
  • There are no fresh company-specific headlines, FDA decisions, or analyst actions to account for the price action.